In a previous study we have demonstrated that a particular form of calreticulin elicits a humoral response in hepatocellular carcinoma (23), with the reactive epitope occurring in a truncated form (CRT32, which includes the C-terminal portion), whereas the intact protein did not elicit reactivity. Here, CALR is linked to hepatocellular carcinoma.